SCHEMBL3047203

SCHEMBL3047203

CC(C)(C)OC(=O)n1c(-c2ccc(Cl)c3c2C(=O)NC3)cc2cc(NC(=O)N3CCNCC3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NR1H2 P55055 5/20 0.35
GPR119 Q8TDV5 2/20 0.35
BRD4 O60885 1/20 0.34
CREBBP Q92793 1/20 0.34
MAPT P10636 1/20 0.34
F13A1 P00488 1/20 0.34
TGM2 P21980 1/20 0.34
TGM1 P22735 1/20 0.34
TGM3 Q08188 1/20 0.34
ATR Q13535 2/20 0.33
ATRIP Q8WXE1 2/20 0.33
KDR P35968 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
NAMPT P43490 1/20 0.33
HTT P42858 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PIM1 P11309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3039340 0.88 BRD4 (0.37) MEN1KMT2ANR1H2GPR119BRD4
SCHEMBL3047016 0.86 PTPN2 (0.47) MEN1KMT2AGPR119MAPTNPC1
SCHEMBL3051536 0.83 ALDH1A1 (0.45) MEN1KMT2ANR1H2GPR119BRD4
SCHEMBL3047590 0.81 NR1H2 (0.45) NR1H2BRD4CREBBPATRATRIP
SCHEMBL3044227 0.81 BRD4 (0.39) NR1H2BRD4CREBBPATRATRIP
SCHEMBL3041591 0.80 MEN1 (0.43) MEN1KMT2ANR1H2GPR119BRD4
SCHEMBL3034386 0.80 BRD4 (0.51) NR1H2BRD4CREBBP
SCHEMBL3043890 0.80 BRD4 (0.38) NR1H2BRD4CREBBPATRATRIP
SCHEMBL3039184 0.79 NR1H2 (0.37) NR1H2BRD4CREBBP
SCHEMBL3046089 0.79 CCNA2 (0.40) MEN1KMT2ANR1H2BRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 MEN1 1165/4885KMT2A 320/4885NR1H2 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.